RNS Number : 3507F Renalytix PLC 01 March 2024 The following amendment has been made to the ' Grant of Share Options ' announcement released on 23 November 2023 at 07:00 under RNS No 3917U . The sentence " All the Share Options granted one twelfth of the Share Options vest 3 months from the
RNS Number : 9346E Renalytix PLC 29 February 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF MAR. THE PERSON RESPONSIBLE FOR ARRANGING THE RELEASE OF THIS ANNOUNCEMENT ON BEHALF OF RENALYTIX IS JAMES MCCULLOUGH , CEO. Renalytix plc ("Renalytix" or the "Company")
LONDON and SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease, today reported financial results for the fiscal second
RNS Number : 2070D Renalytix PLC 15 February 2024 Renalytix plc ("Renalytix" or the "Company") Half Year Report LONDON and SALT LAKE CITY , February 15, 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing
LONDON and SALT LAKE CITY, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”) today announced that the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which will take place February
RNS Number : 6963C Renalytix PLC 09 February 2024 Renalytix plc ("Renalytix" or the "Company") Renalytix to Participate in the BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference LONDON and SALT LAKE CITY , February 9, 2024 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX)
RNS Number : 5654C Renalytix PLC 09 February 2024 Renalytix plc ("Renalytix" or the "Company") Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd LONDON and SALT LAKE CITY , February 9, 2024 - Renalytix plc (NASDAQ:
RNS Number : 9171Z Renalytix PLC 17 January 2024 Renalytix plc ("Renalytix" or the "Company") Update on kidneyIntelX.dkd Local Coverage Determination Consideration Local Coverage Determination would result in contracted coverage for an estimated additional five million Medicare patients
Electronic health record deployment of KidneyIntelX was associated with clinical actions that slowed progression of chronic kidney disease and improved Type 2 diabetes control in just 12 months Results demonstrated a 61% increase in preventative drug prescriptions among patients in the high-risk
RNS Number : 1665Z Renalytix PLC 10 January 2024 Renalytix plc ("Renalytix" or the "Company") New published data for KidneyIntelX™ New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease Electronic health record deployment of
